PT SOHO Global Health (SOHO) Fundamentals 2026 — P/E 23.6x, Revenue Analysis | SniperIQ
PT SOHO Global Health (SOHO) is a ID-listed Healthcare company in Medical - Pharmaceuticals with a market capitalization of Rp15.48T, trading at Rp1220.00 on the JKT. This SniperIQ fundamentals page covers PT SOHO Global Health's valuation (P/E 23.6x, P/B 5.6x), profitability (net margin 6.1%), revenue (Rp10.78T in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is PT SOHO Global Health's market cap?
PT SOHO Global Health (SOHO) has a market capitalization of approximately Rp15.48T, trading at Rp1220.00 on the JKT. Market cap moves with the live share price.
What is PT SOHO Global Health's P/E ratio?
PT SOHO Global Health's trailing twelve-month P/E ratio is 23.6x, with a price-to-book (P/B) of 5.6x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is PT SOHO Global Health?
PT SOHO Global Health runs a net profit margin of 6.1%, a gross margin of 17.3%, and an operating margin of 7.4%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does PT SOHO Global Health generate?
PT SOHO Global Health reported revenue of Rp10.78T for fiscal year 2025, with net income of Rp600.3B and earnings per share (EPS) of 47.3. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does PT SOHO Global Health pay a dividend?
PT SOHO Global Health offers a trailing dividend yield of about 6.0%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is PT SOHO Global Health financially healthy?
PT SOHO Global Health carries a debt-to-equity ratio of 0.00x and a current ratio of 1.83x, with a market beta of 0.87. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is PT SOHO Global Health a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For PT SOHO Global Health (SOHO) the key facts are: market cap Rp15.48T, P/E 23.6x, revenue Rp10.78T, 52-week range 675-4010. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track PT SOHO Global Health's full fundamentals live
Get PT SOHO Global Health's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.